Feasibility, validity and reliability of the Welsh EQ-5D health status questionnaire
Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
StandardStandard
Feasibility, validity and reliability of the Welsh EQ-5D health status questionnaire. / Hughes, D.; Hughes, D.A.
2007. Papur a gyflwynwyd yn 12th Annual International Society for Pharmacoeconomics and Outcomes Research, Arlington, Virginia, USA.
2007. Papur a gyflwynwyd yn 12th Annual International Society for Pharmacoeconomics and Outcomes Research, Arlington, Virginia, USA.
Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
HarvardHarvard
Hughes, D & Hughes, DA 2007, 'Feasibility, validity and reliability of the Welsh EQ-5D health status questionnaire', Papur a gyflwynwyd yn 12th Annual International Society for Pharmacoeconomics and Outcomes Research, Arlington, Virginia, USA, 3/01/02.
APA
Hughes, D., & Hughes, D. A. (2007). Feasibility, validity and reliability of the Welsh EQ-5D health status questionnaire. Papur a gyflwynwyd yn 12th Annual International Society for Pharmacoeconomics and Outcomes Research, Arlington, Virginia, USA.
CBE
Hughes D, Hughes DA. 2007. Feasibility, validity and reliability of the Welsh EQ-5D health status questionnaire. Papur a gyflwynwyd yn 12th Annual International Society for Pharmacoeconomics and Outcomes Research, Arlington, Virginia, USA.
MLA
Hughes, D. a D.A. Hughes Feasibility, validity and reliability of the Welsh EQ-5D health status questionnaire. 12th Annual International Society for Pharmacoeconomics and Outcomes Research, Arlington, Virginia, USA, 03 Ion 0002, Papur, 2007.
VancouverVancouver
Hughes D, Hughes DA. Feasibility, validity and reliability of the Welsh EQ-5D health status questionnaire. 2007. Papur a gyflwynwyd yn 12th Annual International Society for Pharmacoeconomics and Outcomes Research, Arlington, Virginia, USA.
Author
RIS
TY - CONF
T1 - Feasibility, validity and reliability of the Welsh EQ-5D health status questionnaire
AU - Hughes, D.
AU - Hughes, D.A.
PY - 2007/5/1
Y1 - 2007/5/1
M3 - Paper
T2 - 12th Annual International Society for Pharmacoeconomics and Outcomes Research, Arlington, Virginia, USA
Y2 - 3 January 0002
ER -